Rhinovirus-Infected Patients in the COVID-19 Pandemic Period

Figures & data

Table 1 Clinical Characteristics of Human Rhinovirus Infected Patients

#	Age	Male/Female	Detected Virus	Onset Location	Underlying Diseases	Final Diagnosis	Temp ℃	Chest Shadows	Treatment	Improvement	Others/Sample
1	83	F	Rhinovirus	Nursing home	Parkinson diseases	Common cold	37.6	Slightly	Acetaminophen	Yes	None
2	68	M	Rhinovirus	Community	GB stone	Cholecystitis	38	Slightly	MEPM	Yes	E. coli/Blood
3	46	F	Rhinovirus	Community	DM, Collagen	Nephritis	37	None	None	Yes	None
4	88	M	Rhinovirus	Nursing home	CKD, HD	Pneumonia	38	Strong	ABPC/SBT	Yes	S. pneumoniae Ag/Urine
5	5	M	Rhinovirus	Community/Home	None	Cellulitis	37.2	None	CEZ	Yes	S. aureus/Skin
6	37	F	Rhinovirus	Hospital	Collagen	Cellulitis	39	None	AMPC	Yes	None
7	30	M	Rhinovirus	Community	SAS, Atopy	Common cold	39	None	Acetaminophen	Yes	None
8	15	F	Rhinovirus	Community	None	Common cold	38	None	Mucodain	Yes	None
9	12	F	Rhinovirus	Community	None	Otitis media	38	None	Acetaminophen	Yes	None
10	53	F	Rhinovirus	Community	SLE	Bronchiolitis	38	Slightly	LVFX	Yes	None
11	87	M	Rhinovirus	Community	Prostate cancer	Common cold	37.2	Slightly	AMPC	Yes	None

Abbreviations: M, male; F, female; DM, diabetes mellitus; GB, gallbladder; CKD, chronic kidney diseases; HD, hemodialysis; SAS, sleep apnea syndrome; SLE, systemic lupus erythematosus; MEPM, meropenem; ABPC/SBT, ampicillin/sulbactam; CEZ, cefazolin; AMPC, amoxicillin; LVFX, levofloxacin.